Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4081c6c5295416d5f4dc176160dfc5e6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708 |
filingDate |
2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d418f78688785efe215bead7523b62 |
publicationDate |
2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20110062315-A |
titleOfInvention |
Pharmaceutical composition comprising inosine or guanosine |
abstract |
The present invention relates to a pharmaceutical composition for treating or preventing dry eye syndrome comprising inosine or guanosine and a pharmaceutically acceptable carrier. The pharmaceutical composition according to the present invention can be effectively used to treat or prevent dry eye by directly increasing the amount of tears. |
priorityDate |
2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |